Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:inovio_pharmaceuticals [2023/02/27 08:47] liam | pharmaceutical_companies:inovio_pharmaceuticals [2025/01/08 23:26] (current) liam |
---|
| |
===== History ===== | ===== History ===== |
| |
| ==== Founding ==== |
| |
The company was founded on June 29, 1983 as Biotechnologies & Experimental Research, Inc.((Inovio Pharmaceuticals, Inc. //Form 10-K.// Securities and Exchange Commission. Retrieved January 18, 2021, from https://web.archive.org/web/20210118230712/https://www.sec.gov/Archives/edgar/data/1055726/000105572618000014/ino-12312017x10k.htm)) On December 10, 1991, the company changed its corporate name to BTX, Inc. | The company was founded on June 29, 1983 as Biotechnologies & Experimental Research, Inc.((Inovio Pharmaceuticals, Inc. //Form 10-K.// Securities and Exchange Commission. Retrieved January 18, 2021, from https://web.archive.org/web/20210118230712/https://www.sec.gov/Archives/edgar/data/1055726/000105572618000014/ino-12312017x10k.htm)) On December 10, 1991, the company changed its corporate name to BTX, Inc. |
| |
On February 8, 1994, the company changed its name to Genetronics. It went public in April 1994 by exchanging shares with [[Consolidated United Safety Technologies]], which was listed on the [[Vancouver Stock Exchange]] in [[canada:British Columbia]], [[Canada]].((Speights, K. (2017, April 18). //Inovio Pharmaceuticals Stock History: From A to Zika.// The Motley Fool. https://archive.ph/nAPFd)) On September 2, 1997, the company listed on the [[Toronto Stock Exchange]] (TSX). On December 8, 1998, the company listed on the [[American Stock Exchange]] and voluntarily de-listed from the TSX on January 17, 2003. | On February 8, 1994, the company changed its name to Genetronics. It went public in April 1994 by exchanging shares with Consolidated United Safety Technologies, which was listed on the [[:Vancouver Stock Exchange]] in [[canada:British Columbia]], [[:Canada]].((Speights, K. (2017, April 18). //Inovio Pharmaceuticals Stock History: From A to Zika.// The Motley Fool. https://archive.ph/nAPFd)) On September 2, 1997, the company listed on the [[:Toronto Stock Exchange]] (TSX). On December 8, 1998, the company listed on the [[:American Stock Exchange]] and voluntarily de-listed from the TSX on January 17, 2003. |
| |
The company's focus during much of its early period as a U.S. stock was on [[electroporation]], a technology for introducing [[DNA]] and drugs into cells through a brief electrical pulse that causes tiny pores to open in the cell membrane. Genetronics developed drug delivery systems using electroporation and sold electroporation equipment to the research laboratory market. | The company's focus during much of its early period as a U.S. stock was on [[:electroporation]], a technology for introducing [[DNA]] and drugs into cells through a brief electrical pulse that causes tiny pores to open in the cell membrane. Genetronics developed drug delivery systems using electroporation and sold electroporation equipment to the research laboratory market. |
| |
On June 15, 2001, Genetronics Biomedical Ltd. completed a change in jurisdiction of incorporation from British Columbia, Canada, to the state of [[united_states:Delaware]] and became Genetronics Biomedical Corporation. On January 25, 2005, Genetronics Biomedical Corporation acquired Inovio AS, a [[gene delivery]] technology company located in [[Norway]]. | On June 15, 2001, Genetronics Biomedical Ltd. completed a change in jurisdiction of incorporation from British Columbia, Canada, to the state of [[united_states:Delaware]] and became Genetronics Biomedical Corporation. On January 25, 2005, Genetronics Biomedical Corporation acquired Inovio AS, a [[:gene delivery]] technology company located in [[Norway]]. |
| |
On March 31, 2005, Genetronics Biomedical Corporation was renamed Inovio Biomedical Corporation. | On March 31, 2005, Genetronics Biomedical Corporation was renamed Inovio Biomedical Corporation. |
| |
| On June 1, 2009, Inovio Biomedical merged with [[VGX Pharmaceuticals]]. On May 14, 2010, the combined entity changed its corporate name to Inovio Pharmaceuticals, Inc. |
| |
===== Organization ===== | ===== Organization ===== |
| |
| ==== Associations ==== |
| |
Inovio is a member company of the [[:Biotechnology Innovation Organization]] (BIO).((//BIO Member Directory.// Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory)) | Inovio is a member company of the [[:Biotechnology Innovation Organization]] (BIO).((//BIO Member Directory.// Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory)) |
| |
* [[https://sites.google.com/housatonicits.com/home0003/research/inovio-pharmaceuticals-inc|Housatonic]] | * [[https://sites.google.com/housatonicits.com/home0003/research/inovio-pharmaceuticals-inc|Housatonic]] |
| * [[https://www.whiteroseintelligence.com/inovio-pharmaceuticals/|White Rose Wiki]] |
* [[https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals|Wikipedia]] | * [[https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals|Wikipedia]] |